Polyclonal anti-whole cell IgY passive immunotherapy shields against P. aeruginosa-induced acute pneumonia and burn wound infections in murine models
Abstract Pseudomonas aeruginosa (PA) is a multidrug-resistant (MDR) opportunistic pathogen causing severe hospital-, and community-acquired infections worldwide. Thus, the development of effective immunotherapy-based treatments is essential to combat the MDR-PA infections. In the current study, we e...
Main Authors: | Tooba Sadat Ahmadi, Bahador Behrouz, Seyed Latif Mousavi Gargari |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-50859-x |
Similar Items
-
Feasibility of Polyclonal Avian Immunoglobulins (IgY) as Prophylaxis against Human Norovirus Infection
by: Chad Artman, et al.
Published: (2022-10-01) -
Anti-SpCas9 IgY Polyclonal Antibodies Production for CRISPR Research Use
by: Esteban León, et al.
Published: (2023-09-01) -
IgY Antibodies as Biotherapeutics in Biomedicine
by: Diana León-Núñez, et al.
Published: (2022-09-01) -
IgYs: on her majesty’s secret service
by: Renata Grzywa, et al.
Published: (2023-06-01) -
Trends in industrialization and commercialization of IgY technology
by: Saeed Yakhkeshi, et al.
Published: (2022-10-01)